Global Intracranial Hemorrhage Therapeutics Market Size By Treatment Type (Surgery, Medications), By End-User (Hospitals, Ambulatory Surgery Centers), By Geographic Scope And Forecast

Intracranial Hemorrhage Therapeutics Market Size And Forecast

Intracranial Hemorrhage Therapeutics Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030.

One of the major factors driving the growth and demand of the intracranial hemorrhage diagnosis and treatment market is the rapidly rising prevalence of aneurysms. Furthermore, the growing geriatric population and age-related brain disorders are expected to drive global market growth over the forecast period. The market is also growing due to an increase in the number of road accidents and increased spending on healthcare infrastructure. Furthermore, rapid technological advancements combined with research and development activities, as well as the growing popularity and progress of nanotechnology, are all contributing to the growth of the intracranial hemorrhage diagnosis and treatment market.

Global Intracranial Hemorrhage Therapeutics Market Definition

Bleeding within the skull is known as intracranial hemorrhage (ICH). Intracerebral bleeds (intraventricular and intraparenchymal bleeds), subarachnoid bleeds, epidural bleeds, and subdural bleeds are all subtypes of intracerebral bleeds. It usually results in death. Each year, 2.5 out of 10,000 people experience intracerebral bleeding. Intracranial hemorrhage is a serious medical emergency because the accumulation of blood within the skull can cause intracranial pressure to rise, crushing delicate brain tissue or restricting its blood supply. Brain herniation occurs when parts of the brain are squeezed past structures in the skull due to severe intracranial pressure (ICP) increases.

Intracranial hemorrhage is most frequently caused by trauma. Epidural, subdural, and subarachnoid hemorrhage are all possible complications. Trauma can also result in other conditions like hemorrhagic parenchymal contusion and cerebral microhemorrhages. Hypertension, cerebral amyloid angiopathy, hemorrhagic conversion of ischemic infarction, cerebral aneurysms, dural arteriovenous fistulae, cerebral venous sinus thrombosis, cerebral vasculitis, and mycotic aneurysm are all examples of non-traumatic causes of hemorrhage. Hypertension is responsible for more than half of all intracranial hemorrhages.

Intracerebral hemorrhage is a life-threatening condition for which no specific treatment has been shown to reduce mortality in a randomized controlled trial. However, it appears that management in a neuroscience intensive care unit improves outcomes, implying that many of the currently available therapies are effective. Reversal of anticoagulation and modest blood pressure reduction are two strategies used in the acute phase of intracerebral hemorrhage treatment to minimize ongoing bleeding. Many organizations also recommend monitoring and controlling glucose levels, temperature, and, in some cases, intracranial pressure. Hematoma evacuation and external ventricular drainage may be beneficial to some patients.

Global Intracranial Hemorrhage Therapeutics Market Overview

The growth drivers for the market are a large number of patients suffering from brain cancer, aneurysm, and related conditions, a growing number of incidences of trauma and accidents leading to Traumatic Brain Injury (TBI), clinical trials to improve available treatments, and increasing healthcare expenditure. Over the forecast period, the Global Intracranial Hemorrhage Therapeutics Market is expected to grow due to the rising incidence of risk factors associated with brain hemorrhages such as head injury, high blood pressure, brain tumor, aneurysm, and others.

According to data released by the National Center for Biotechnology Information in August 2021, the global prevalence of cerebral aneurysms (brain artery weakening) is around 3.2 percent, with a risk of rupture resulting in subarachnoid hemorrhage of about 10 per 100,000 cases. According to the same source, after the age of 50, the prevalence of cerebral aneurysms rises in females due to lower estrogen levels, which leads to less collagen in vascular tissue, weakening blood vessel walls. The restraints for the market growth are increasing counterfeit drugs & side effects of the treatment and a lack of skilled workforce. Whereas the opportunities are, new product launches in developing regions.

Global Intracranial Hemorrhage Therapeutics MarketSegmentation Analysis

The Global Intracranial Hemorrhage Therapeutics Market is segmented on the basis of Treatment Type, End-User, And Geography.

Intracranial Hemorrhage Therapeutics Market, By Treatment Type

• Surgery• Medications

Based on Treatment Type, The market is segmented into Surgery and Medications. Most people who have a brain hemorrhage prefer to use Medications to treat the problem. The Medications segment is divided into anti-hypertensive drugs, anti-anxiety drugs, hyperosmotic drugs, and anti-seizure drugs. The anti-hypertensive drugs segment dominates the market and is expected to maintain its lead throughout the forecast period. This is because antihypertensive medications are the first line of treatment for brain hemorrhage.

Intracranial Hemorrhage Therapeutics Market, By End-User

• Hospitals• Ambulatory Surgery Centers• Others

Based on End-User, The market is segmented into Hospitals, Ambulatory Surgery Centers, and Others. The Hospitals segment currently dominates the market, and this trend is expected to continue during the forecasted period.

Intracranial Hemorrhage Therapeutics Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global Intracranial Hemorrhage Therapeutics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America dominates the global market due to the high prevalence of traumatic brain injuries in the United States. The Asia Pacific Intracranial Hemorrhage Therapeutics Market is expected to grow at the fastest CAGR due to an increase in brain hemorrhage incidence, a surge in awareness, and improvements in health care infrastructure.

Key Players

The “Global Intracranial Hemorrhage Therapeutics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Baxter, Oxurion NV, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Novartis AG, Bayer AG, Abbott, Bristol-Myers Squibb, Johnson and Johnson, Novo Nordisk, L H. Lundbeck, Ligand Pharmaceuticals, Neurotec Pharma.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In October 2019, iSchemaView, Inc. launched RAPID ICH, its newest rapid platform addition. This system uses artificial intelligence to prioritize non-contrast CT scans and alert clinicians about the possibility of intracranial hemorrhage.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.